BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruyssers NE, De Winter BY, De Man JG, Loukas A, Herman AG, Pelckmans PA, Moreels TG. Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol 2008;2008:567314. [PMID: 18509490 DOI: 10.1155/2008/567314] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Salgado VCL, Luiz RR, Boechat N, Schorr BC, Leão IS, Nunes T, Zaltman C. Crohn’s disease environmental factors in the developing world: A case-control study in a statewide catchment area in Brazil. World J Gastroenterol 2017; 23(30): 5549-5556 [PMID: 28852314 DOI: 10.3748/wjg.v23.i30.5549] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Dixit A, Tanaka A, Greer JM, Donnelly S. Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms. Int J Mol Sci 2017;18:E2141. [PMID: 29027962 DOI: 10.3390/ijms18102141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
3 Harnett W, Harnett MM. Helminth-derived immunomodulators: can understanding the worm produce the pill? Nat Rev Immunol 2010;10:278-84. [PMID: 20224568 DOI: 10.1038/nri2730] [Cited by in Crossref: 138] [Cited by in F6Publishing: 137] [Article Influence: 12.5] [Reference Citation Analysis]
4 Maruszewska-Cheruiyot M, Donskow-Łysoniewska K, Doligalska M. Helminth Therapy: Advances in the use of Parasitic Worms Against Inflammatory Bowel Diseases and its Challenges. Helminthologia 2018;55:1-11. [PMID: 31662622 DOI: 10.1515/helm-2017-0048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Donskow-Łysoniewska K, Krawczak K, Bocian K, Doligalska M. The Effects of Intestinal Nematode L4 Stage on Mouse Experimental Autoimmune Encephalomyelitis. Arch Immunol Ther Exp (Warsz) 2018;66:231-43. [PMID: 28975357 DOI: 10.1007/s00005-017-0489-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Cho MK, Park MK, Kang SA, Choi SH, Ahn SC, Yu HS. Trichinella spiralis infection suppressed gut inflammation with CD4(+)CD25(+)Foxp3(+) T cell recruitment. Korean J Parasitol 2012;50:385-90. [PMID: 23230342 DOI: 10.3347/kjp.2012.50.4.385] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang J, Goepfert C, Mueller N, Piersigilli A, Lin R, Wen H, Vuitton DA, Vuitton L, Mueller C, Gottstein B. Larval Echinococcus multilocularis infection reduces dextran sulphate sodium-induced colitis in mice by attenuating T helper type 1/type 17-mediated immune reactions. Immunology 2018;154:76-88. [PMID: 29121394 DOI: 10.1111/imm.12860] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Castenmiller C, Keumatio-Doungtsop BC, van Ree R, de Jong EC, van Kooyk Y. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance. Front Immunol 2021;12:643240. [PMID: 33679806 DOI: 10.3389/fimmu.2021.643240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Van Brussel I, Lee WP, Rombouts M, Nuyts AH, Heylen M, De Winter BY, Cools N, Schrijvers DM. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality? Autoimmunity Reviews 2014;13:138-50. [DOI: 10.1016/j.autrev.2013.09.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
10 Shepherd C, Navarro S, Wangchuk P, Wilson D, Daly NL, Loukas A. Identifying the immunomodulatory components of helminths. Parasite Immunol 2015;37:293-303. [PMID: 25854639 DOI: 10.1111/pim.12192] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
11 Ferreira I, Smyth D, Gaze S, Aziz A, Giacomin P, Ruyssers N, Artis D, Laha T, Navarro S, Loukas A, McSorley HJ. Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis. Infect Immun 2013;81:2104-11. [PMID: 23545299 DOI: 10.1128/IAI.00563-12] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
12 Parian AM, Mullin GE, Langhorst J, Brown AC. Inflammatory Bowel Disease. Integrative Medicine. Elsevier; 2018. pp. 501-516.e8. [DOI: 10.1016/b978-0-323-35868-2.00050-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Misra SM. Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence. Children (Basel) 2014;1:149-65. [PMID: 27417473 DOI: 10.3390/children1020149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Ramani S, Chauhan N, Khatri V, Vitali C, Kalyanasundaram R. Wuchereria bancrofti macrophage migration inhibitory factor-2 (rWbaMIF-2) ameliorates experimental colitis. Parasite Immunol 2020;42:e12698. [PMID: 31976564 DOI: 10.1111/pim.12698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mckay DM. The therapeutic helminth? Trends in Parasitology 2009;25:109-14. [DOI: 10.1016/j.pt.2008.11.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
16 Vukman KV, Lalor R, Aldridge A, O'Neill SM. Mast cells: new therapeutic target in helminth immune modulation. Parasite Immunol 2016;38:45-52. [PMID: 26577605 DOI: 10.1111/pim.12295] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
17 D'Elia R, Behnke JM, Bradley JE, Else KJ. Regulatory T cells: a role in the control of helminth-driven intestinal pathology and worm survival. J Immunol 2009;182:2340-8. [PMID: 19201888 DOI: 10.4049/jimmunol.0802767] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
18 McSorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev 2012;25:585-608. [PMID: 23034321 DOI: 10.1128/CMR.05040-11] [Cited by in Crossref: 303] [Cited by in F6Publishing: 170] [Article Influence: 37.9] [Reference Citation Analysis]
19 Esmat S, El Nady M, Elfekki M, Elsherif Y, Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol 2014; 20(3): 814-821 [PMID: 24574754 DOI: 10.3748/wjg.v20.i3.814] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
20 Ruyssers NE, De Winter BY, De Man JG, Ruyssers ND, Van Gils AJ, Loukas A, Pearson MS, Weinstock JV, Pelckmans PA, Moreels TG. Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol 2010; 16(6): 703-712 [PMID: 20135718 DOI: 10.3748/wjg.v16.i6.703] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
21 Taghipour N, Mosaffa N, Aghdaei HA, Rostami-Nejad M, Weinstock JV, Shahnavaz S, Zali MR. Immunomodulatory effect of Syphacia obvelata in treatment of experimental DSS-induced colitis in mouse model. Sci Rep 2019;9:19127. [PMID: 31836772 DOI: 10.1038/s41598-019-55552-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Veluswamy H, Suryawala K, Sheth A, Wells S, Salvatierra E, Cromer W, Chaitanya GV, Painter A, Patel M, Manas K. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol. 2010;10:104. [PMID: 20828408 DOI: 10.1186/1471-230x-10-104] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
23 van den Enden E. Pharmacotherapy of helminth infection. Expert Opinion on Pharmacotherapy 2009;10:435-51. [DOI: 10.1517/14656560902722463] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
24 Cooper PJ, Chico ME, Guadalupe I, Sandoval CA, Mitre E, Platts-Mills TA, Barreto ML, Rodrigues LC, Strachan DP, Griffin GE. Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study. BMC Infect Dis 2011;11:184. [PMID: 21714922 DOI: 10.1186/1471-2334-11-184] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
25 Tilp C, Kapur V, Loging W, Erb KJ. Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy. Int J Parasitol. 2013;43:319-325. [PMID: 23291462 DOI: 10.1016/j.ijpara.2012.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
26 Bruschi F, Chiumiento L, Prete GD. Immunodulation and Helminths: Towards New Strategies for Treatment of Immune-Mediated Diseases? In: Viola Magni M, editor. Detection of Bacteria, Viruses, Parasites and Fungi. Dordrecht: Springer Netherlands; 2010. pp. 357-80. [DOI: 10.1007/978-90-481-8544-3_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Junginger J, Schwittlick U, Lemensieck F, Nolte I, Hewicker-Trautwein M. Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs. Vet Res 2012;43:23. [PMID: 22440243 DOI: 10.1186/1297-9716-43-23] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
28 Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011; 17(5): 578-593 [PMID: 21350707 DOI: 10.3748/wjg.v17.i5.578] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 91] [Article Influence: 9.1] [Reference Citation Analysis]
29 Turner JD, Jenkins GR, Hogg KG, Aynsley SA, Paveley RA, Cook PC, Coles MC, Mountford AP. CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection. PLoS Negl Trop Dis 2011;5:e1269. [PMID: 21858239 DOI: 10.1371/journal.pntd.0001269] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
30 Benzel F, Erdur H, Kohler S, Frentsch M, Thiel A, Harms L, Wandinger KP, Rosche B. Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients. J Helminthol. 2012;86:339-347. [PMID: 21838960 DOI: 10.1017/s0022149x11000460] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
31 Kang SA, Park MK, Park SK, Choi JH, Lee DI, Song SM, Yu HS. Adoptive transfer of Trichinella spiralis-activated macrophages can ameliorate both Th1- and Th2-activated inflammation in murine models. Sci Rep 2019;9:6547. [PMID: 31024043 DOI: 10.1038/s41598-019-43057-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
32 Gordon CA, Kurscheid J, Jones MK, Gray DJ, McManus DP. Soil-Transmitted Helminths in Tropical Australia and Asia. Trop Med Infect Dis 2017;2:E56. [PMID: 30270913 DOI: 10.3390/tropicalmed2040056] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
33 Heylen M, Ruyssers NE, Gielis EM, Vanhomwegen E, Pelckmans PA, Moreels TG, De Man JG, De Winter BY. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease. Pharmacol Ther 2014;143:153-67. [PMID: 24603369 DOI: 10.1016/j.pharmthera.2014.02.011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]